For help on how to get the results you want, see our search tips.
8 results
Application type
Initial authorisation Remove Initial authorisation filter
Post-authorisation Remove Post-authorisation filter
Categories
Human Remove Human filter
Opinion status
Negative Remove Negative filter
-
List item
Summary of opinion: Flynpovi
eflornithine, sulindac, opinion date: 24/06/2021, Negative, Last updated: 23/07/2021 -
List item
Summary of opinion: Raylumis
tanezumab, opinion date: 16/09/2021, Negative, Last updated: 17/09/2021 -
List item
Summary of opinion: Trelegy Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Ipique
bevacizumab, opinion date: 11/11/2021, Negative, Last updated: 12/11/2021 -
List item
Summary of opinion: Aduhelm
aducanumab, opinion date: 16/12/2021, Negative, Last updated: 17/12/2021 -
List item
Summary of opinion: Elebrato Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Temybric Ellipta
fluticasone furoate, umeclidinium, vilanterol, opinion date: 25/02/2021, Negative, Last updated: 26/02/2021 -
List item
Summary of opinion: Siklos
hydroxycarbamide, opinion date: 22/07/2021, Negative, Last updated: 23/07/2021